- Home
- Publications
- Publication Search
- Publication Details
Title
Genetics of CD33 in Alzheimer's disease and acute myeloid leukemia
Authors
Keywords
-
Journal
HUMAN MOLECULAR GENETICS
Volume 24, Issue 12, Pages 3557-3570
Publisher
Oxford University Press (OUP)
Online
2015-03-12
DOI
10.1093/hmg/ddv092
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The past and future of CD33 as therapeutic target in acute myeloid leukemia
- (2014) George S. Laszlo et al. BLOOD REVIEWS
- CD33: increased inclusion of exon 2 implicates the Ig V-set domain in Alzheimer's disease susceptibility
- (2014) T. Raj et al. HUMAN MOLECULAR GENETICS
- Negative Regulation of Toll-like Receptor-4 Signaling through the Binding of Glycosylphosphatidylinositol-anchored Glycoprotein, CD14, with the Sialic Acid-binding Lectin, CD33
- (2014) Akiko Ishida et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Clinical Significance of CD33 Nonsynonymous Single-Nucleotide Polymorphisms in Pediatric Patients with Acute Myeloid Leukemia Treated with Gemtuzumab-Ozogamicin-Containing Chemotherapy
- (2013) L. Mortland et al. CLINICAL CANCER RESEARCH
- CD33 Alzheimer's Risk-Altering Polymorphism, CD33 Expression, and Exon 2 Splicing
- (2013) M. Malik et al. JOURNAL OF NEUROSCIENCE
- Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
- (2013) Jean-Charles Lambert et al. NATURE GENETICS
- CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology
- (2013) Elizabeth M Bradshaw et al. NATURE NEUROSCIENCE
- Alzheimer’s Disease Risk Gene CD33 Inhibits Microglial Uptake of Amyloid Beta
- (2013) Ana Griciuc et al. NEURON
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Alzheimer’s Disease: Analyzing the Missing Heritability
- (2013) Perry G. Ridge et al. PLoS One
- Correlation of CD33 expression level with disease characteristics and response to gemtuzumab ozogamicin containing chemotherapy in childhood AML
- (2012) J. A. Pollard et al. BLOOD
- Regulation of cyclin T1 expression and function by an alternative splice variant that skips exon 7 and contains a premature termination codon
- (2012) Emiko Urano et al. GENE
- Microglial activatory (immunoreceptor tyrosine-based activation motif)- and inhibitory (immunoreceptor tyrosine-based inhibition motif)-signaling receptors for recognition of the neuronal glycocalyx
- (2012) Bettina Linnartz et al. GLIA
- Genetics of Clusterin Isoform Expression and Alzheimer's Disease Risk
- (2012) I-Fang Ling et al. PLoS One
- Epitope mapping, expression and post-translational modifications of two isoforms of CD33 (CD33M and CD33m) on lymphoid and myeloid human cells
- (2011) A. B. Perez-Oliva et al. GLYCOBIOLOGY
- Replication of EPHA1 and CD33 associations with late-onset Alzheimer's disease: a multi-centre case-control study
- (2011) Minerva M Carrasquillo et al. Molecular Neurodegeneration
- Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
- (2011) Adam C Naj et al. NATURE GENETICS
- Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
- (2011) Paul Hollingworth et al. NATURE GENETICS
- Interaction of PABPC1 with the translation initiation complex is critical to the NMD resistance of AUG-proximal nonsense mutations
- (2011) I. Peixeiro et al. NUCLEIC ACIDS RESEARCH
- Mechanism of escape from nonsense-mediated mRNA decay of human -globin transcripts with nonsense mutations in the first exon
- (2011) G. Neu-Yilik et al. RNA
- What Happened to Anti-CD33 Therapy for Acute Myeloid Leukemia?
- (2011) Joseph G. Jurcic Current Hematologic Malignancy Reports
- MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes
- (2010) Yun Li et al. GENETIC EPIDEMIOLOGY
- Anti-leukemic activity of Lintuzumab (SGN-33) in preclinical models of acute myeloid leukemia
- (2010) May Kung Sutherland et al. mAbs
- The mammalian nonsense-mediated mRNA decay pathway: To decay or not to decay! Which players make the decision?
- (2009) Ana Luísa Silva et al. FEBS LETTERS
- CD14 and Toll-Like Receptors 2 and 4 Are Required for Fibrillar A -Stimulated Microglial Activation
- (2009) E. G. Reed-Geaghan et al. JOURNAL OF NEUROSCIENCE
- Neuropathology and Cognitive Impairment in Alzheimer Disease: A Complex but Coherent Relationship
- (2008) Peter T. Nelson et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Coding polymorphisms in CD33 and response to gemtuzumab ozogamicin in pediatric patients with AML: a pilot study
- (2008) J K Lamba et al. LEUKEMIA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started